# Apoha

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/apoha

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.apoha.com
- Total disclosed funding: $44M
- Latest round: Series A (May 21, 2026)
- Investors on record: 9

## About

Apoha Limited is a UK-based company focused on developing innovative AI technologies that enhance molecular science understanding. Their solutions support advancements in pharmaceuticals, food, and materials science through sophisticated data analysis.Founded in 2021 and headquartered in London, UK, Apoha Limited specializes in advanced AI technologies that facilitate molecular science research. The company has conducted 3 investment deals and recently secured GBP 26.70 mn in a Series A funding round, led by Singular, with participation from Draper, Nucleus Capital, Redalpine, Seedcamp, and Wilbe Capital. The founder's background details are not publicly available, and there have been no reported pivots in the company's strategy.Apoha specializes in developing advanced AI technologies designed to enhance the understanding of molecular science. Their core product offerings focus on creating a data layer that enables machines to analyze and interpret molecular structures, supporting the design of innovative solutions in pharmaceuticals, food, and materials science. Catering to biotech, food, and beverage industries, Apoha empowers researchers and developers to create better medicines, optimize food products, and improve material properties. The company provides tailored services to pharmaceutical companies, biotech firms, and food manufacturers primarily in the United States and Europe, addressing critical challenges in molecular research and applications.Apoha's revenue model is centered around B2B transactions with clients in the pharmaceutical and food industries. Through partnerships and subscription-based services, clients access Apoha's proprietary technologies to enhance their R&D capabilities. Customized solutions are provided based on specific client needs, with flexible pricing structures tailored to the scope of services rendered. The flagship offerings include AI-driven tools for molecular data analysis, accommodating a tiered pricing approach corresponding to service levels and technological integration.Apoha Limited aims to expand its product offerings with new AI tools designed to enhance molecular data analysis, with specific release dates yet to be announced. The company plans to target new markets in North America and Asia by the end of 2024. The recent GBP 26.70 mn funding will be utilized to support these initiatives, including product development and market entry strategies. Furthermore, Apoha has previously raised an undisclosed amount in Seed funding from investors such as Redalpine, Seedcamp, Wilbe Capital, and Nucleus Capital.

## Funding rounds

- Series A, May 21, 2026, $36M — Seedcamp, Plug and Play, Acequia Capital, Redalpine, R7 Partners, Draper, Singular, Nucleus Capital, Wilbe Capital
- Seed, Oct 3, 2023, $8.3M — Seedcamp, Redalpine

## Investors

- Seedcamp (https://capitalatlas.ai/funds/seedcamp) — Seed, Series A
- Redalpine (https://capitalatlas.ai/funds/redalpine) — Seed, Series A
- Plug and Play (https://capitalatlas.ai/funds/plug-and-play) — Series A
- Acequia Capital (https://capitalatlas.ai/funds/acequia-capital) — Series A
- R7 Partners (https://capitalatlas.ai/funds/r7-partners) — Series A
- Draper (https://capitalatlas.ai/funds/draper) — Series A
- Singular (https://capitalatlas.ai/funds/singular) — Series A
- Nucleus Capital (https://capitalatlas.ai/funds/nucleus-capital) — Series A
- Wilbe Capital (https://capitalatlas.ai/funds/wilbe-capital) — Series A